TrialAmerican journal of hematology2024

Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.

Alexandra Power-Hays et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.